Identification of novel HIV-1-derived HLA-E-binding peptides

Non-classical class Ib MHC-E molecule is becoming an increasingly interesting component of the immune response. It is involved in both the adaptive and innate immune responses to several chronic infections including HIV-1 and, under very specific circumstances, likely mediated a unique vaccine prote...

Full description

Bibliographic Details
Main Authors: Hannoun, Z, Lin, Z, Brackenridge, S, Kuse, N, Akahoshi, T, Borthwick, N, McMichael, A, Murakoshi, H, Takiguchi, M, Hanke, T
Format: Journal article
Language:English
Published: Elsevier 2018
_version_ 1797055252255473664
author Hannoun, Z
Lin, Z
Brackenridge, S
Kuse, N
Akahoshi, T
Borthwick, N
McMichael, A
Murakoshi, H
Takiguchi, M
Hanke, T
author_facet Hannoun, Z
Lin, Z
Brackenridge, S
Kuse, N
Akahoshi, T
Borthwick, N
McMichael, A
Murakoshi, H
Takiguchi, M
Hanke, T
author_sort Hannoun, Z
collection OXFORD
description Non-classical class Ib MHC-E molecule is becoming an increasingly interesting component of the immune response. It is involved in both the adaptive and innate immune responses to several chronic infections including HIV-1 and, under very specific circumstances, likely mediated a unique vaccine protection of rhesus macaques against pathogenic SIV challenge. Despite being recently in the spotlight for HIV-1 vaccine development, to date there is only one reported human leukocyte antigen (HLA)-E-binding peptide derived from HIV-1. In an effort to help start understanding the possible functions of HLA-E in HIV-1 infection, we determined novel HLA-E binding peptides derived from HIV-1 Gag, Pol and Vif proteins. These peptides were identified in three independent assays, all quantifying cell-surface stabilization of HLA-E*01:01 or HLA-E*01:03 molecules upon peptide binding, which was detected by HLA-E-specific monoclonal antibody and flow cytometry. Thus, following initial screen of over 400 HIV-1-derived 15-mer peptides, 4 novel 9-mer peptides PM9, RL9, RV9 and TP9 derived from 15-mer binders specifically stabilized surface expression of HLA-E*01:03 on the cell surface in two separate assays and 5 other binding candidates EI9, MD9, NR9, QF9 and YG9 gave a binding signal in only one of the two assays, but not both. Overall, we have expanded the current knowledge of HIV-1-derived target peptides stabilizing HLA-E cell-surface expression from 1 to 5, thus broadening inroads for future studies. This is a small, but significant contribution towards studying the fine mechanisms behind HLA-E actions and their possible use in development of a new kind of vaccines.
first_indexed 2024-03-06T19:08:02Z
format Journal article
id oxford-uuid:15d3f57a-8eb0-41b3-a05c-b0c139f58593
institution University of Oxford
language English
last_indexed 2024-03-06T19:08:02Z
publishDate 2018
publisher Elsevier
record_format dspace
spelling oxford-uuid:15d3f57a-8eb0-41b3-a05c-b0c139f585932022-03-26T10:27:44ZIdentification of novel HIV-1-derived HLA-E-binding peptidesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:15d3f57a-8eb0-41b3-a05c-b0c139f58593EnglishSymplectic Elements at OxfordElsevier2018Hannoun, ZLin, ZBrackenridge, SKuse, NAkahoshi, TBorthwick, NMcMichael, AMurakoshi, HTakiguchi, MHanke, TNon-classical class Ib MHC-E molecule is becoming an increasingly interesting component of the immune response. It is involved in both the adaptive and innate immune responses to several chronic infections including HIV-1 and, under very specific circumstances, likely mediated a unique vaccine protection of rhesus macaques against pathogenic SIV challenge. Despite being recently in the spotlight for HIV-1 vaccine development, to date there is only one reported human leukocyte antigen (HLA)-E-binding peptide derived from HIV-1. In an effort to help start understanding the possible functions of HLA-E in HIV-1 infection, we determined novel HLA-E binding peptides derived from HIV-1 Gag, Pol and Vif proteins. These peptides were identified in three independent assays, all quantifying cell-surface stabilization of HLA-E*01:01 or HLA-E*01:03 molecules upon peptide binding, which was detected by HLA-E-specific monoclonal antibody and flow cytometry. Thus, following initial screen of over 400 HIV-1-derived 15-mer peptides, 4 novel 9-mer peptides PM9, RL9, RV9 and TP9 derived from 15-mer binders specifically stabilized surface expression of HLA-E*01:03 on the cell surface in two separate assays and 5 other binding candidates EI9, MD9, NR9, QF9 and YG9 gave a binding signal in only one of the two assays, but not both. Overall, we have expanded the current knowledge of HIV-1-derived target peptides stabilizing HLA-E cell-surface expression from 1 to 5, thus broadening inroads for future studies. This is a small, but significant contribution towards studying the fine mechanisms behind HLA-E actions and their possible use in development of a new kind of vaccines.
spellingShingle Hannoun, Z
Lin, Z
Brackenridge, S
Kuse, N
Akahoshi, T
Borthwick, N
McMichael, A
Murakoshi, H
Takiguchi, M
Hanke, T
Identification of novel HIV-1-derived HLA-E-binding peptides
title Identification of novel HIV-1-derived HLA-E-binding peptides
title_full Identification of novel HIV-1-derived HLA-E-binding peptides
title_fullStr Identification of novel HIV-1-derived HLA-E-binding peptides
title_full_unstemmed Identification of novel HIV-1-derived HLA-E-binding peptides
title_short Identification of novel HIV-1-derived HLA-E-binding peptides
title_sort identification of novel hiv 1 derived hla e binding peptides
work_keys_str_mv AT hannounz identificationofnovelhiv1derivedhlaebindingpeptides
AT linz identificationofnovelhiv1derivedhlaebindingpeptides
AT brackenridges identificationofnovelhiv1derivedhlaebindingpeptides
AT kusen identificationofnovelhiv1derivedhlaebindingpeptides
AT akahoshit identificationofnovelhiv1derivedhlaebindingpeptides
AT borthwickn identificationofnovelhiv1derivedhlaebindingpeptides
AT mcmichaela identificationofnovelhiv1derivedhlaebindingpeptides
AT murakoshih identificationofnovelhiv1derivedhlaebindingpeptides
AT takiguchim identificationofnovelhiv1derivedhlaebindingpeptides
AT hanket identificationofnovelhiv1derivedhlaebindingpeptides